About the role:
A three year position is available in the laboratory of Georges Lacaud to investigate the role of genes specifically expressed in leukaemic cells and to further validate and progress them as potential therapeutic targets.
Leukaemia is the 8th most common cause of cancer death in Europe. The main goal of the Stem Cell Biology group is to identify new therapies for Acute Myeloid Leukaemia (AML). Treatments of AML have not dramatically changed, or improved, in the last 30 years and there is therefore a pressing need for the development of more specific and efficient therapies. In this context, the group is particularly interested in investigating the role and requirements of transcription factors recurrently rearranged or mutated in human leukaemias such as the master regulator of blood development AML1/RUNX1 or the transcriptional co-activator MOZ.
About you:
You should have a PhD in molecular or cellular biology (or a relevant field). Relevant experience in haematopoiesis or leukaemia working with cellular or in vivo models is essential. Bioinformatic skills are desirable. Key qualities should include independent thinking, ability to work in a team and good communication skills, all of which are needed to efficiently work in a multidisciplinary team.
Why choose Cancer Research UK Manchester Institute?
The Cancer Research UK Manchester Institute (
www.cruk.manchester.ac.uk), an Institute of The University of Manchester (
www.manchester.ac.uk), is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (
www.cancerresearchuk.org), the largest independent cancer research organisation in the world. We are currently situated at the internationally renowned life sciences campus at Alderley Park in Cheshire England, 15 miles from Manchester, a vibrant and dynamic city surrounded by beautiful countryside.
We are partnered with The Christie NHS Foundation Trust (adjacent to the CRUK Manchester Institute, Paterson Building) in South Manchester (
www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.
How to apply:
To apply for this position please visit our website:
http://www.cruk.manchester.ac.uk/Opportunities/Opportunities-Home Informal enquiries should be directed to Georges Lacaud via email:
[email protected] Closing date: 16 July 2018.
